Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nutrients ; 12(2)2020 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-32019160

RESUMO

Vitamin D status has been implicated in obesity and adipose tissue inflammation. In the present study, we explored the effects of dietary vitamin D supplementation on adipose tissue inflammation and immune cell population, and the effects of in vitro 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) treatment on pro-inflammatory cytokine production by stromal vascular cells (SVCs) and adipocytes in lean and high-fat diet-induced obese mice. The results show that epididymal fat Mcp-1 and Rantes mRNA levels, which were higher in obese mice compared with lean mice, were significantly down-regulated by vitamin D supplementation. While obese mice had higher numbers of macrophages and natural killer (NK) cells within adipose tissue, these remained unaltered by vitamin D supplementation. In accordance with these in vivo findings, the in vitro 1,25(OH)2D3 treatment decreased IL-6, MCP-1, and IL-1ß production by SVCs from obese mice, but not by adipocytes. In addition, 1,25(OH)2D3 treatment significantly decreased Tlr2 expression and increased mRNA levels of Iκba and Dusp1 in SVCs. These findings suggest that vitamin D supplementation attenuates inflammatory response in adipose tissue, especially in SVCs, possibly through inhibiting NF-κB and MAPK signaling pathways in SVCs but not by the inhibition of macrophage infiltration.


Assuntos
Adipócitos/efeitos dos fármacos , Calcitriol/farmacologia , Obesidade/imunologia , Células Estromais/efeitos dos fármacos , Vitaminas/farmacologia , Adipócitos/imunologia , Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/imunologia , Animais , Citocinas/efeitos dos fármacos , Citocinas/imunologia , Dieta Hiperlipídica , Modelos Animais de Doenças , Inflamação , Camundongos , Camundongos Obesos , Obesidade/terapia , Células Estromais/imunologia
2.
Environ Health Perspect ; 128(1): 17008, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31922426

RESUMO

BACKGROUND: Sharing research data uses resources effectively; enables large, diverse data sets; and supports rigor and reproducibility. However, sharing such data increases privacy risks for participants who may be re-identified by linking study data to outside data sets. These risks have been investigated for genetic and medical records but rarely for environmental data. OBJECTIVES: We evaluated how data in environmental health (EH) studies may be vulnerable to linkage and we investigated, in a case study, whether environmental measurements could contribute to inferring latent categories (e.g., geographic location), which increases privacy risks. METHODS: We identified 12 prominent EH studies, reviewed the data types collected, and evaluated the availability of outside data sets that overlap with study data. With data from the Household Exposure Study in California and Massachusetts and the Green Housing Study in Boston, Massachusetts, and Cincinnati, Ohio, we used k-means clustering and principal component analysis to investigate whether participants' region of residence could be inferred from measurements of chemicals in household air and dust. RESULTS: All 12 studies included at least two of five data types that overlap with outside data sets: geographic location (9 studies), medical data (9 studies), occupation (10 studies), housing characteristics (10 studies), and genetic data (7 studies). In our cluster analysis, participants' region of residence could be inferred with 80%-98% accuracy using environmental measurements with original laboratory reporting limits. DISCUSSION: EH studies frequently include data that are vulnerable to linkage with voter lists, tax and real estate data, professional licensing lists, and ancestry websites, and exposure measurements may be used to identify subgroup membership, increasing likelihood of linkage. Thus, unsupervised sharing of EH research data potentially raises substantial privacy risks. Empirical research can help characterize risks and evaluate technical solutions. Our findings reinforce the need for legal and policy protections to shield participants from potential harms of re-identification from data sharing. https://doi.org/10.1289/EHP4817.


Assuntos
Revelação , Saúde Ambiental , Disseminação de Informação , Privacidade
3.
Nutr Res ; 67: 90-99, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30995974

RESUMO

Inflammatory bowel disease (IBD) often accompanies vitamin D deficiency, and vitamin D supplementation ameliorates IBD symptoms in animal models and humans. Because altered vitamin D metabolism has been reported in obesity, we hypothesized that the effects of vitamin D on the development of IBD would be different between obese and control mice. Five-week-old male C57BL/6N mice were divided into 4 groups and fed a diet differing in fat content (10% or 45%, normal diet [ND] or high-fat diet [HFD]) and vitamin D content (1000 or 10 000 IU/kg of diet, vDC or vDS) for 14 weeks. At week 13, colitis was induced by administration of 2% dextran sodium sulfate for 7 days. Histology score tended to be lower in the HFD-vDS group than HFD-vDC group, but there was no effect of vitamin D on the ND group. Colonic Cldn1 and Cyp27b1 mRNA levels were higher in the HFD-vDS than HFD-vDC group, but these effects of vitamin D were not observed in the ND group. The serum 25-hydroxy vitamin D levels were negatively correlated with the histology score in the HFD group but not in the ND group. Overall, these results suggest that vitamin D supplementation partially prevents the histological damage of the colon in obese mice but not in control mice. This effect might be mediated by increased colonic Cyp27b1 levels, leading to upregulation of local 1,25-dihydroxy vitamin D production.


Assuntos
Colite/complicações , Colite/tratamento farmacológico , Sulfato de Dextrana/administração & dosagem , Suplementos Nutricionais , Obesidade/complicações , Vitamina D/farmacologia , Animais , Colo/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Obesos , Vitamina D/administração & dosagem , Vitaminas/administração & dosagem , Vitaminas/farmacologia
4.
Technol Sci ; 20172017.
Artigo em Inglês | MEDLINE | ID: mdl-30687852

RESUMO

Researchers are increasingly asked to share research data as part of publication and funding processes and to maximize the benefits of publicly funded research. The Safe Harbor provision of the U.S. Health Information Portability and Accountability Act (HIPAA) offers guidance to researchers by prescribing how to redact data for public sharing. For example, the provision requires removing explicit identifiers (such as name, address and other personally identifiable information), reporting dates in years, and reducing some or all digits of a postal (or ZIP) code. Is this sufficient? Can research participants still be re-identified in research data that adhere to the HIPAA Safe Harbor standard? In 2006, researchers collected air and dust samples and interviewed residents of 50 homes from Bolinas and Richmond (Atchison Village and Liberty Village), California, to analyze the residents' exposure to pollutants. The study, known as the Northern California Household Exposure Study [1], led to publications that have been cited hundreds of times. We conducted experiments with separate "attacker" and "scorer" teams to see whether we could identify study participants from two versions of the data redacted beyond the HIPAA standard, one in which all dates were reported in ranges of 10 or 20 years and another in which a study participant's birth year was reported exactly. The attackers were blinded to the names and addresses of the participants, and the scorers were blinded to the strategy.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...